1. Home
  2. PTCT vs AMED Comparison

PTCT vs AMED Comparison

Compare PTCT & AMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • AMED
  • Stock Information
  • Founded
  • PTCT 1998
  • AMED 1982
  • Country
  • PTCT United States
  • AMED United States
  • Employees
  • PTCT N/A
  • AMED N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • AMED Medical/Nursing Services
  • Sector
  • PTCT Health Care
  • AMED Health Care
  • Exchange
  • PTCT Nasdaq
  • AMED Nasdaq
  • Market Cap
  • PTCT 3.9B
  • AMED 3.2B
  • IPO Year
  • PTCT 2013
  • AMED N/A
  • Fundamental
  • Price
  • PTCT $48.55
  • AMED $97.18
  • Analyst Decision
  • PTCT Buy
  • AMED Hold
  • Analyst Count
  • PTCT 14
  • AMED 5
  • Target Price
  • PTCT $63.57
  • AMED $100.80
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • AMED 486.4K
  • Earning Date
  • PTCT 08-07-2025
  • AMED 07-23-2025
  • Dividend Yield
  • PTCT N/A
  • AMED N/A
  • EPS Growth
  • PTCT N/A
  • AMED N/A
  • EPS
  • PTCT 7.51
  • AMED 2.72
  • Revenue
  • PTCT $1,772,758,000.00
  • AMED $2,371,691,000.00
  • Revenue This Year
  • PTCT $121.50
  • AMED $6.29
  • Revenue Next Year
  • PTCT N/A
  • AMED $5.25
  • P/E Ratio
  • PTCT $6.45
  • AMED $35.97
  • Revenue Growth
  • PTCT 91.12
  • AMED 5.34
  • 52 Week Low
  • PTCT $29.02
  • AMED $82.15
  • 52 Week High
  • PTCT $58.38
  • AMED $98.95
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 46.94
  • AMED 54.07
  • Support Level
  • PTCT $47.52
  • AMED $95.55
  • Resistance Level
  • PTCT $49.73
  • AMED $97.92
  • Average True Range (ATR)
  • PTCT 1.46
  • AMED 0.70
  • MACD
  • PTCT -0.19
  • AMED -0.11
  • Stochastic Oscillator
  • PTCT 36.28
  • AMED 55.44

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About AMED Amedisys Inc

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Share on Social Networks: